Argeris N. Karabelas, Chairman of the Board at Vanda Pharmaceuticals Inc. (VNDA), sold 320,000 shares at $15.29 ($4.6M) on 2006-11-20, disclosed to the SEC on 2006-11-22.
Open-market sale of $4.6M VNDA by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.25 | 17,334 | $247K | 5.4% |
| 2 | $14.25 | 252,666 | $3.6M | 78.1% |
| 3 | $15.29 | 3,210 | $49K | 1.1% |
| 4 | $15.29 | 46,790 | $715K | 15.5% |
| Total | $14.41 avg | 320,000 | $4.6M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |